{"favorite_id": 10240, "calc_type": "", "dosing": false, "full_title_en": "CLIF-C ACLF (Acute-on-Chronic Liver Failure)", "short_title_en": "CLIF-C ACLF", "medium_description_en": "Predicts mortality in acute-on-chronic liver failure.", "short_description_en": "Mortality in liver failure.", "before_use": "", "instructions_en": "<p>Use in adult patients with decompensated chronic (cirrhotic) liver disease; it does not predict outcome in acute liver failure.</p>", "purpose_en": ["Prognosis"], "disease_en": ["Cirrhosis", "Hepatitis", "Hepatocellular Carcinoma"], "specialty_en": ["Gastroenterology", "Hepatology", "Hospitalist Medicine", "Internal Medicine"], "chief_complaint_en": ["Abdominal Pain", "Jaundice"], "system_en": ["Gastrointestinal", "Hepatic"], "search_abbreviation_en": ["CLIF-C ACLF", "CLIF-C ACLF (Acute-on-Chronic Liver Failure)", "clif aclf", "clif-of", "clif-c of", "clif organ failure", "aclf", "acute on chronic liver failure", "liver failure", "aclf score", "clif aclf score", "clif-c aclf score"], "slug": "clif-c-aclf-acute-chronic-liver-failure", "seo": {"meta_description_en": "The CLIF-C ACLF (Acute-on-Chronic Liver Failure) predicts mortality in acute-on-chronic liver failure.", "keywords_en": "CLIF-C ACLF, CLIF-C ACLF (Acute-on-Chronic Liver Failure), clif aclf, clif-of, clif-c of, clif organ failure, aclf, acute on chronic liver failure, liver failure, aclf score, clif aclf score, clif-c aclf score"}, "content": {"how_to_use": {"use_case_en": "<p>Adult patients with decompensated cirrhotic liver disease and a clinical suspicion of failure of one or more organ systems.</p>", "pearls_pitfalls_en": "<p><span id=\"docs-internal-guid-34aeaef8-7fff-4140-3e47-0e2e0ee9a32e\"></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Decompensated liver disease is generally defined as the development of jaundice, ascites, encephalopathy, upper GI bleed, bacterial infection, or a combination of these, in a patient with existing cirrhotic liver disease.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">ACLF is a relatively new concept, characterized by a systemic inflammatory response as well as multiple organ failures (including decompensation of chronic liver disease).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Short term mortality in ACLF is high, around 25-75% at 28 days (<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23474284\" target=\"_blank\">Moreau 2013</a>).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">The first part of the score counts the number of failing organ systems; the second part incorporates age and white cell count to calculate an ACLF score and a predicted mortality rate.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">A score of &gt;65 is associated with 100% mortality 3-7 days after diagnosis of ACLF.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">In up to 50% of patients, the precipitating cause of ACLF remains unidentified. Common causes include sepsis, ongoing alcohol consumption, and relapse of viral hepatitis.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">This study is not validated in or designed for use in patients with acute liver failure (for example, those with acetaminophen overdose or fulminant but de novo viral hepatitis) in the absence of pre-existing chronic liver disease.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">The derivation and validation studies were trialed in patients admitted to a critical care unit; therefore, its accuracy with regards to patients who are managed medically without a higher level care is not known.</p>\n</li>\n</ul>", "why_use_en": "<p><span id=\"docs-internal-guid-17e837e4-7fff-a492-e89e-43829d3e47cd\"></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">May be used to predict 1-, 3-, 6- and 12-month mortality.&nbsp;</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">A predicted mortality of 100% after 48 hours of ICU treatment might give insights on futility of ongoing organ support.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">The score can be used dynamically; an increasing score despite intensive organ support might prompt a discussion about withdrawal of treatment, whereas a decrease in score after 48 hours might suggest a positive response to treatment.</p>\n</li>\n</ul>"}, "next_steps": {"advice_en": "<p><span id=\"docs-internal-guid-c3810033-7fff-c3bb-0e9d-cc1fc215bf23\"></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">The score can be recalculated after 48 hours as a marker of response to treatment.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">If there is no acute-on-chronic liver failure (ACLF grade 0), the CLIF-C AD (acute decompensation) score can be used instead to predict mortality.</p>\n</li>\n</ul>", "management_en": "<p><span id=\"docs-internal-guid-bcebf89d-7fff-e9fb-754b-a93aad10739a\"></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">There is no single specific treatment for ACLF. Management is focused on organ support and treatment of reversible causes.&nbsp;</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Remember that sepsis can often be difficult to spot in patients with cirrhosis. Infection was identified as a potential precipitating factor in around a third of patients in the derivation study.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Take blood, urine, and ascitic fluid samples to identify possible infection. Consider empiric use of antibiotics.</p>\n</li>\n</ul>", "critical_actions_en": "<p>Discuss with the patient and with critical care colleagues as appropriate regarding options for escalation of care.</p>"}, "about": {"formula_en": "<p dir=\"ltr\">CLIF-C ACLF Score = 10 x [0.33 x CLIF Organ Failure Score + 0.04 x age, years + 0.63 x ln(WBC count, 10<sup>9</sup> cells/L) - 2],&nbsp;</p>\n<p dir=\"ltr\">where CLIF Organ Failure Score = addition of the selected points:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /></colgroup>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p dir=\"ltr\"><strong>Variable</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Points</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p dir=\"ltr\"><strong>Liver</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p dir=\"ltr\">Bilirubin</p>\n</td>\n<td>\n<p dir=\"ltr\">&lt;6 mg/dL (&lt;102.6 &micro;mol/L)</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">6 to &lt;12 mg/dL (102.6 to &lt;205.2 &micro;mol/L)</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&ge;12 mg/dL (&ge;205.2 &micro;mol/L)</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p dir=\"ltr\"><strong>Kidney</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p dir=\"ltr\">Creatinine</p>\n</td>\n<td>\n<p dir=\"ltr\">&lt;2 mg/dL (&lt;176.8 &micro;mol/L)</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">2 to &lt;3.5 mg/dL (176.8 to &lt;309.4 &micro;mol/L)</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&ge;3.5 mg/dL (&ge;309.4 &micro;mol/L) or renal replacement therapy</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p dir=\"ltr\"><strong>Brain</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p dir=\"ltr\"><calculator id=\"674\">West-Haven Grade for Hepatic Encephalopathy</calculator></p>\n</td>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1-2</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">3-4 (or if patient is intubated due to hepatic encephalopathy and not respiratory failure*)</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p dir=\"ltr\"><strong>Coagulation</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p dir=\"ltr\"><abbr title=\"International normalized ratio\">INR</abbr></p>\n</td>\n<td>\n<p dir=\"ltr\">&lt;2.0</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">2.0 to &lt;2.5</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&ge;2.5</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p dir=\"ltr\"><strong>Circulatory</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p dir=\"ltr\"><calculator id=\"74\">MAP</calculator>, mmHg</p>\n</td>\n<td>\n<p dir=\"ltr\">&ge;70</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&lt;70</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Any MAP with vasopressors</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p dir=\"ltr\"><strong>Respiratory (use PaO<sub>2</sub>/FiO<sub>2</sub> ratio or SpO<sub>2</sub>/FiO<sub>2</sub><span style=\"font-size: xx-small;\"> ratio)</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p dir=\"ltr\"><abbr title=\"Partial pressure of oxygen\">PaO<sub>2</sub></abbr>/<abbr title=\"Fraction of inspired oxygen\">FiO<sub>2</sub></abbr> ratio</p>\n</td>\n<td>\n<p dir=\"ltr\">&gt;300</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&gt;200 to 300</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&le;200 (or if patient intubated for respiratory failure)</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p dir=\"ltr\"><abbr title=\"Oxygen saturation\">SpO<sub>2</sub></abbr>/<abbr title=\"Fraction of inspired oxygen\">FiO<sub>2</sub></abbr> ratio</p>\n</td>\n<td>\n<p dir=\"ltr\">&gt;357</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&gt;214 to 357</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&le;214 (or if patient intubated for respiratory failure)</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p><span id=\"docs-internal-guid-2aea767b-7fff-8128-8a30-27f0656d87ea\"><span id=\"docs-internal-guid-2aea767b-7fff-8128-8a30-27f0656d87ea\">*Patients submitted to mechanical ventilation due to hepatic encephalopathy and not due to a respiratory failure are considered as presenting a cerebral failure (cerebral subscore = 3).</p>", "more_info_en": "<p dir=\"ltr\">Interpretation:</p>\n<p dir=\"ltr\">Probability of death at a given time = 1 - e<sup>y</sup>, where y = -CI x exp(&beta; x CLIF-C ACLF Score), where Cl and &beta; are as follows:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Time</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Cumulative baseline hazard (Cl)</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Coefficient (&beta;)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1 month</p>\n</td>\n<td>\n<p dir=\"ltr\">0.0022</p>\n</td>\n<td>\n<p dir=\"ltr\">0.0995</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">3 months</p>\n</td>\n<td>\n<p dir=\"ltr\">0.0079</p>\n</td>\n<td>\n<p dir=\"ltr\">0.0869</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">6 months</p>\n</td>\n<td>\n<p dir=\"ltr\">0.0115</p>\n</td>\n<td>\n<p dir=\"ltr\">0.0824</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1 year</p>\n</td>\n<td>\n<p dir=\"ltr\">0.0231</p>\n</td>\n<td>\n<p dir=\"ltr\">0.0731</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p><span id=\"docs-internal-guid-1e5ee5b3-7fff-bc3b-6d13-c1105bb63b22\">From <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/24950482\" target=\"_blank\">Jalan 2014</a>.</p>", "evidence_based_medicine_en": "<p dir=\"ltr\">The initial study identified 275 patients with ACLF from a prospective observational study of 1,349 hospitalized patients with cirrhosis and acute decompensation (<a href=\"https://www.journal-of-hepatology.eu/article/S0168-8278(14)00408-5/fulltext\" target=\"_blank\">Jalan 2014</a>). These patients were analyzed using an organ failure score combined with age and WBC, both independent predictors of outcome, to derive the CLIF-C ACLF score. Using a concordance index, the CLIF-C ACLF was shown to be more accurate than <calculator id=\"78\">MELD</calculator>, <calculator id=\"1754\">MELD-Na</calculator>, and <calculator id=\"340\">Child-Pugh</calculator> in predicting mortality, both in the CANONIC group and in an external cohort. The accuracy in predicting 28 day mortality is improved when the CLIF-C ACLF score is calculated at 48 hours (or 3-7 days) after ACLF diagnosis.</p>\n<p><span id=\"docs-internal-guid-82bcf1e3-7fff-34f4-4b14-7207f37f0f17\">The <a href=\"https://ccforum.biomedcentral.com/articles/10.1186/s13054-018-2156-0\" target=\"_blank\">external validation study</a> was a retrospective analysis of 202 patients with acute-on-chronic liver failure admitted to the intensive care unit at the Royal Free Hospital, London, UK. The authors calculated CLIF-C ACLF, <calculator id=\"340\">Child-Pugh</calculator>, and <calculator id=\"78\">MELD</calculator> scores 48 hours after ICU admission and compared predictions of outcome at 28 days. CLIF-C ACLF outperformed the other scores on <abbr title=\"Area under the receiver operating characteristics curve\">AUROC</abbr> analysis, and further demonstrated that CLIF-C ACLF &gt;70 identified patients with 100% mortality at 28 days.</p>", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/24950482", "text": "Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61(5):1038-47."}], "Other References": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/23474284", "text": "Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426-37, 1437.e1-9."}], "Validation": [{"href": "http://onlinelibrary.wiley.com/doi/10.1111/liv.12683/abstract;jsessionid=7DD64E523F2EBCDEB7BD8D4E0079DAE6.f04t03", "text": "Lee M, Lee JH, Oh S, et al. CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis. Liver Int. 2015;35(1):46-57."}, {"href": "https://ccforum.biomedcentral.com/articles/10.1186/s13054-018-2156-0", "text": "Engelmann C, Thomsen KL, Zakeri N, et al. Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure. Crit Care. 2018;22(1):254."}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"description": "", "firstName": "Callum", "img": "", "lastName": "Wood", "name": "Callum Wood, MB, BChir, MRCP (UK)", "target": "", "signedCOI": false, "hasDisclosure": []}]}, "creator": [{"name": "Dr. Rajiv Jalan", "qa_en": "", "approved": false, "creator_info": {"about_en": "<p>Rajiv Jalan, MBBS, MRCP, is a professor of hepatology at the Institute for Liver and Digestive Health at University College London in UK.  Dr. Jalan\u2019s primary research is focused on\u00a0acute-on-chronic liver failure.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-rajiv-jalan.jpeg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Jalan+R%5BAuthor%5D"}}], "reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"label_en": "Age", "conditionality": "", "default": null, "tips_en": "", "optional": false, "name": "age", "unit": "age", "type": "textbox", "unit_info": {"name": "Age", "conversion": 1, "error_min": 0.001, "error_max": 120, "warn_min": 0.1, "warn_max": 100, "normal_max_si": 0, "normal_min_si": 0, "normal_min_us": 0, "units_si": "years", "units_us": "years"}}, {"label_en": "WBC count", "conditionality": "", "default": null, "tips_en": "", "optional": false, "name": "wbc", "unit": "wbc", "type": "textbox", "unit_info": {"name": "White Blood Cell Count", "conversion": 1, "error_min": 0.0001, "error_max": 500, "warn_min": 0.1, "warn_max": 100, "normal_max_si": 10.7, "normal_min_si": 3.7, "normal_min_us": 3.7, "units_si": "\u00d7 10\u2079 cells/L", "units_us": "\u00d7 10\u00b3 cells/\u00b5L", "normal_max_us": 10.7}}, {"subheading": "Liver", "subheading_instructions": "", "type": "subheading"}, {"type": "radio", "label_en": "Bilirubin", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "<6 mg/dL (<102.6 \u00b5mol/L)", "value": 1}, {"label": "6 to <12 mg/dL (102.6 to <205.2 \u00b5mol/L)", "value": 2}, {"label": "\u226512 mg/dL (\u2265205.2 \u00b5mol/L)", "value": 3}], "name": "bili"}, {"subheading": "Kidney", "subheading_instructions": "", "type": "subheading"}, {"type": "radio", "label_en": "Creatinine", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "<2 mg/dL (<176.8 \u00b5mol/L)", "value": 1}, {"label": "2 to <3.5 mg/dL (176.8 to <309.4 \u00b5mol/L)", "value": 2}, {"label": "\u22653.5 mg/dL (\u2265309.4 \u00b5mol/L) or renal replacement therapy", "value": 3}], "name": "cr"}, {"subheading": "Brain", "subheading_instructions": "", "type": "subheading"}, {"type": "radio", "label_en": "<calculator id = \"674\">West-Haven Grade for Hepatic Encephalopathy</calculator>", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Patients intubated due to hepatic encephalopathy (and not respiratory failure) should be scored as +3", "optional": false, "options": [{"label": "0", "value": 1}, {"label": "1-2", "value": 2}, {"label": "3-4 ", "value": 3}], "name": "grade"}, {"subheading": "Coagulation", "subheading_instructions": "", "type": "subheading"}, {"type": "radio", "label_en": "<abbr title = \"International normalized ratio\">INR</abbr>", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "<2.0", "value": 1}, {"label": "2.0 to <2.5", "value": 2}, {"label": "\u22652.5", "value": 3}], "name": "inr"}, {"subheading": "Circulatory", "subheading_instructions": "", "type": "subheading"}, {"type": "radio", "label_en": "<abbr title =\"Mean arterial pressure\">MAP</abbr>, mmHg", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "\u226570", "value": 1}, {"label": "<70", "value": 2}, {"label": "Any MAP with vasopressors", "value": 3}], "name": "map"}, {"subheading": "Respiratory", "subheading_instructions": "", "type": "subheading"}, {"type": "radio", "label_en": "Information available", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "PaO<sub>2</sub>/FiO<sub>2</sub> ratio", "value": 0}, {"label": "SpO<sub>2</sub>/FiO<sub>2</sub> ratio", "value": 1}], "name": "resp"}, {"type": "radio", "label_en": "<abbr title=\"Partial pressure of oxygen\">PaO<sub>2</sub></abbr>/<abbr title=\"Fraction of inspired oxygen\">FiO<sub>2</sub></abbr> ratio", "default": 0, "conditionality": "resp == 0", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": ">300", "value": 1}, {"label": ">200 to 300", "value": 2}, {"label": "\u2264200 (or if patient intubated for respiratory failure)", "value": 3}], "name": "resp1"}, {"type": "radio", "label_en": "<abbr title=\"Oxygen saturation\">SpO<sub>2</sub></abbr>/<abbr title=\"Fraction of inspired oxygen\">FiO<sub>2</sub></abbr> ratio", "default": 0, "conditionality": "resp == 1", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": ">357", "value": 1}, {"label": ">214 to 357", "value": 2}, {"label": "\u2264214 (or if patient intubated for respiratory failure)", "value": 3}], "name": "resp2"}], "md5": "", "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "related_calcs": [{"calcId": 340, "short_title_en": "Child-Pugh Score", "slug": "child-pugh-score-cirrhosis-mortality"}, {"calcId": 78, "short_title_en": "MELD Score (New)", "slug": "meld-score-model-end-stage-liver-disease-12-older"}, {"calcId": 10147, "short_title_en": "UKELD Score", "slug": "united-kingdom-model-end-stage-liver-disease-ukeld"}]}